Selected research
Market Outlook & Growth Opportunities
Global Pharmaceutical Cold Chain Packaging Solutions Market Outlook and Growth Opportunities 2026
Market perspective
The global Pharmaceutical Cold Chain Packaging Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Pharmaceutical Cold Chain Packaging Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Cold Chain Packaging Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Cold Chain Packaging Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Pharmaceutical Cold Chain Packaging Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Pharmaceutical Cold Chain Packaging Solutions market include ThermoSafe, Eutecma, Sofrigam, CoolPac, Cold Chain Technologies, Tempack, Tower Cold Chain, Insulated Products Corporation and World Courier, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Pharmaceutical Cold Chain Packaging Solutions market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmaceutical Cold Chain Packaging Solutions and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmaceutical Cold Chain Packaging Solutions revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Cold Chain Packaging Solutions market.
Pharmaceutical Cold Chain Packaging Solutions Segment by Company
ThermoSafe
Eutecma
Sofrigam
CoolPac
Cold Chain Technologies
Tempack
Tower Cold Chain
Insulated Products Corporation
World Courier
Inmark
Cryopak
TempAid
Sealed Air
Ripplepak
Flexpak
MP Global Packaging
Yusen Logistics
Tessol
EMBALL'ISO
GENSHU
Pharmaceutical Cold Chain Packaging Solutions Segment by Type
Passive Cold Chain Packaging
Active Cold Chain Packaging
Pharmaceutical Cold Chain Packaging Solutions Segment by Application
Vaccines
Reagents
Others
Pharmaceutical Cold Chain Packaging Solutions Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Pharmaceutical Cold Chain Packaging Solutions status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Pharmaceutical Cold Chain Packaging Solutions key companies, revenue, market share, and recent developments.
3. To split the Pharmaceutical Cold Chain Packaging Solutions breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Pharmaceutical Cold Chain Packaging Solutions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pharmaceutical Cold Chain Packaging Solutions significant trends, drivers, influence factors in global and regions.
6. To analyze Pharmaceutical Cold Chain Packaging Solutions competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Cold Chain Packaging Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Cold Chain Packaging Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Cold Chain Packaging Solutions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Cold Chain Packaging Solutions industry.
Chapter 3: Detailed analysis of Pharmaceutical Cold Chain Packaging Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Pharmaceutical Cold Chain Packaging Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Pharmaceutical Cold Chain Packaging Solutions in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Passive Cold Chain Packaging
- Active Cold Chain Packaging
Applications
- Vaccines
- Reagents
- Others
Companies covered
- ThermoSafe
- Eutecma
- Sofrigam
- CoolPac
- Cold Chain Technologies
- Tempack
- Tower Cold Chain
- Insulated Products Corporation
- World Courier
- Inmark
- Cryopak
- TempAid
- Sealed Air
- Ripplepak
- Flexpak
- MP Global Packaging
- Yusen Logistics
- Tessol
- EMBALL'ISO
- GENSHU
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pharmaceutical Cold Chain Packaging Solutions Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pharmaceutical Cold Chain Packaging Solutions Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pharmaceutical Cold Chain Packaging Solutions Market Dynamics
- 2.1 Pharmaceutical Cold Chain Packaging Solutions Industry Trends
- 2.2 Pharmaceutical Cold Chain Packaging Solutions Industry Drivers
- 2.3 Pharmaceutical Cold Chain Packaging Solutions Industry Opportunities and Challenges
- 2.4 Pharmaceutical Cold Chain Packaging Solutions Industry Restraints
3 Pharmaceutical Cold Chain Packaging Solutions Market by Company
- 3.1 Global Pharmaceutical Cold Chain Packaging Solutions Company Revenue Ranking in 2025
- 3.2 Global Pharmaceutical Cold Chain Packaging Solutions Revenue by Company (2021-2026)
- 3.3 Global Pharmaceutical Cold Chain Packaging Solutions Company Ranking (2024-2026)
- 3.4 Global Pharmaceutical Cold Chain Packaging Solutions Company Manufacturing Base and Headquarters
- 3.5 Global Pharmaceutical Cold Chain Packaging Solutions Company Product Type and Application
- 3.6 Global Pharmaceutical Cold Chain Packaging Solutions Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Pharmaceutical Cold Chain Packaging Solutions Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Pharmaceutical Cold Chain Packaging Solutions Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Cold Chain Packaging Solutions Market by Type
- 4.1 Pharmaceutical Cold Chain Packaging Solutions Type Introduction
- 4.1.1 Passive Cold Chain Packaging
- 4.1.2 Active Cold Chain Packaging
- 4.2 Global Pharmaceutical Cold Chain Packaging Solutions Sales Value by Type
- 4.2.1 Global Pharmaceutical Cold Chain Packaging Solutions Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pharmaceutical Cold Chain Packaging Solutions Sales Value by Type (2021-2032)
- 4.2.3 Global Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type (2021-2032)
5 Pharmaceutical Cold Chain Packaging Solutions Market by Application
- 5.1 Pharmaceutical Cold Chain Packaging Solutions Application Introduction
- 5.1.1 Vaccines
- 5.1.2 Reagents
- 5.1.3 Others
- 5.2 Global Pharmaceutical Cold Chain Packaging Solutions Sales Value by Application
- 5.2.1 Global Pharmaceutical Cold Chain Packaging Solutions Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pharmaceutical Cold Chain Packaging Solutions Sales Value by Application (2021-2032)
- 5.2.3 Global Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application (2021-2032)
6 Pharmaceutical Cold Chain Packaging Solutions Regional Value Analysis
- 6.1 Global Pharmaceutical Cold Chain Packaging Solutions Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharmaceutical Cold Chain Packaging Solutions Sales Value by Region (2021-2032)
- 6.2.1 Global Pharmaceutical Cold Chain Packaging Solutions Sales Value by Region: 2021-2026
- 6.2.2 Global Pharmaceutical Cold Chain Packaging Solutions Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharmaceutical Cold Chain Packaging Solutions Sales Value (2021-2032)
- 6.3.2 North America Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Pharmaceutical Cold Chain Packaging Solutions Sales Value (2021-2032)
- 6.4.2 Europe Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Pharmaceutical Cold Chain Packaging Solutions Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Pharmaceutical Cold Chain Packaging Solutions Sales Value (2021-2032)
- 6.6.2 South America Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Pharmaceutical Cold Chain Packaging Solutions Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Cold Chain Packaging Solutions Country-level Value Analysis
- 7.1 Global Pharmaceutical Cold Chain Packaging Solutions Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Pharmaceutical Cold Chain Packaging Solutions Sales Value by Country (2021-2032)
- 7.2.1 Global Pharmaceutical Cold Chain Packaging Solutions Sales Value by Country (2021-2026)
- 7.2.2 Global Pharmaceutical Cold Chain Packaging Solutions Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.7.2 France Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.14.2 China Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.17.2 India Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Pharmaceutical Cold Chain Packaging Solutions Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Pharmaceutical Cold Chain Packaging Solutions Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 ThermoSafe
- 8.1.1 ThermoSafe Company Information
- 8.1.2 ThermoSafe Business Overview
- 8.1.3 ThermoSafe Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.1.4 ThermoSafe Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.1.5 ThermoSafe Recent Developments
- 8.2 Eutecma
- 8.2.1 Eutecma Company Information
- 8.2.2 Eutecma Business Overview
- 8.2.3 Eutecma Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.2.4 Eutecma Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.2.5 Eutecma Recent Developments
- 8.3 Sofrigam
- 8.3.1 Sofrigam Company Information
- 8.3.2 Sofrigam Business Overview
- 8.3.3 Sofrigam Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.3.4 Sofrigam Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.3.5 Sofrigam Recent Developments
- 8.4 CoolPac
- 8.4.1 CoolPac Company Information
- 8.4.2 CoolPac Business Overview
- 8.4.3 CoolPac Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.4.4 CoolPac Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.4.5 CoolPac Recent Developments
- 8.5 Cold Chain Technologies
- 8.5.1 Cold Chain Technologies Company Information
- 8.5.2 Cold Chain Technologies Business Overview
- 8.5.3 Cold Chain Technologies Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.5.4 Cold Chain Technologies Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.5.5 Cold Chain Technologies Recent Developments
- 8.6 Tempack
- 8.6.1 Tempack Company Information
- 8.6.2 Tempack Business Overview
- 8.6.3 Tempack Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.6.4 Tempack Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.6.5 Tempack Recent Developments
- 8.7 Tower Cold Chain
- 8.7.1 Tower Cold Chain Company Information
- 8.7.2 Tower Cold Chain Business Overview
- 8.7.3 Tower Cold Chain Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.7.4 Tower Cold Chain Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.7.5 Tower Cold Chain Recent Developments
- 8.8 Insulated Products Corporation
- 8.8.1 Insulated Products Corporation Company Information
- 8.8.2 Insulated Products Corporation Business Overview
- 8.8.3 Insulated Products Corporation Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.8.4 Insulated Products Corporation Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.8.5 Insulated Products Corporation Recent Developments
- 8.9 World Courier
- 8.9.1 World Courier Company Information
- 8.9.2 World Courier Business Overview
- 8.9.3 World Courier Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.9.4 World Courier Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.9.5 World Courier Recent Developments
- 8.10 Inmark
- 8.10.1 Inmark Company Information
- 8.10.2 Inmark Business Overview
- 8.10.3 Inmark Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.10.4 Inmark Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.10.5 Inmark Recent Developments
- 8.11 Cryopak
- 8.11.1 Cryopak Company Information
- 8.11.2 Cryopak Business Overview
- 8.11.3 Cryopak Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.11.4 Cryopak Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.11.5 Cryopak Recent Developments
- 8.12 TempAid
- 8.12.1 TempAid Company Information
- 8.12.2 TempAid Business Overview
- 8.12.3 TempAid Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.12.4 TempAid Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.12.5 TempAid Recent Developments
- 8.13 Sealed Air
- 8.13.1 Sealed Air Company Information
- 8.13.2 Sealed Air Business Overview
- 8.13.3 Sealed Air Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.13.4 Sealed Air Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.13.5 Sealed Air Recent Developments
- 8.14 Ripplepak
- 8.14.1 Ripplepak Company Information
- 8.14.2 Ripplepak Business Overview
- 8.14.3 Ripplepak Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.14.4 Ripplepak Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.14.5 Ripplepak Recent Developments
- 8.15 Flexpak
- 8.15.1 Flexpak Company Information
- 8.15.2 Flexpak Business Overview
- 8.15.3 Flexpak Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.15.4 Flexpak Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.15.5 Flexpak Recent Developments
- 8.16 MP Global Packaging
- 8.16.1 MP Global Packaging Company Information
- 8.16.2 MP Global Packaging Business Overview
- 8.16.3 MP Global Packaging Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.16.4 MP Global Packaging Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.16.5 MP Global Packaging Recent Developments
- 8.17 Yusen Logistics
- 8.17.1 Yusen Logistics Company Information
- 8.17.2 Yusen Logistics Business Overview
- 8.17.3 Yusen Logistics Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.17.4 Yusen Logistics Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.17.5 Yusen Logistics Recent Developments
- 8.18 Tessol
- 8.18.1 Tessol Company Information
- 8.18.2 Tessol Business Overview
- 8.18.3 Tessol Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.18.4 Tessol Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.18.5 Tessol Recent Developments
- 8.19 EMBALL'ISO
- 8.19.1 EMBALL'ISO Company Information
- 8.19.2 EMBALL'ISO Business Overview
- 8.19.3 EMBALL'ISO Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.19.4 EMBALL'ISO Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.19.5 EMBALL'ISO Recent Developments
- 8.20 GENSHU
- 8.20.1 GENSHU Company Information
- 8.20.2 GENSHU Business Overview
- 8.20.3 GENSHU Pharmaceutical Cold Chain Packaging Solutions Revenue and Gross Margin (2021-2026)
- 8.20.4 GENSHU Pharmaceutical Cold Chain Packaging Solutions Product Portfolio
- 8.20.5 GENSHU Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst